BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2019
View Archived Issues
Knockout of presenilin-1 reduces T-cell acute lymphoblastic leukemia
Read More
EssexBio and Mitotech announce promising topline data from VISTA-1 phase III study
Read More
PIQUR announces treatment of first subject in first-in-human study of topical bimiralisib
Read More
Swedish MPA approves first-in-human trial of ILP-100
Read More
Mechanism of action exploration for the clinical-stage compound PRI-002
Read More
Discovery of novel P2X7R antagonists for the treatment of neurodegenerative disease
Read More
Biallelic variants in COX4I1 linked to a novel phenotype resembling Leigh syndrome
Read More
Guangzhou Maxinovel Pharmaceuticals patents PD-1/PD-L1 interaction inhibitors
Read More
New E3 ubiquitin-protein ligase Mdm2 inhibitors disclosed by Gan & Lee Pharmaceuticals
Read More
Asahi Kasei Pharma discovers prostanoid EP4 receptor agonists
Read More
Rpxds identifies dual FTO/COMT inhibitors
Read More
Inactivation of RBPJ leads to improper communication in brain pericytes and vascular malformations
Read More
GlaxoSmithKline patents receptor-interacting serine/threonine-protein kinase 1 inhibitors
Read More
CCR9 and OSM found to predict efficacy of PF-00547659 in patients with ulcerative colitis
Read More
At HIV Science meeting, lively discussion on what a cure will take
Read More
Biohaven receives complete response letter for Nurtec
Read More
China NMPA clears initiation of phase I bridging registrational study of Tibsovo
Read More
VISIBLE 2 trial of subcutaneous vedolizumab in Crohn's disease meets primary endpoint
Read More
Hypertrophic cardiomyopathy model shows potential of phosphomimetic-RLC gene therapy
Read More
Ascentage initiates phase Ib study in China with APG-1252 and osimertinib in NSCLC
Read More
U.S. approval for Otezla to treat oral ulcers associated with Behcet's disease
Read More
Hamlet reports outcome of phase I/II study of Alpha1H in bladder cancer
Read More
Tiziana reports preliminary topline data from phase IIa trial of milciclib in advanced HCC
Read More
